Skip to main content
Veterinary Medicines

Ataxxa 500 mg/100 mg spot-on solution for dogs over 4 kg up to 10 kg

Authorised
  • Permethrin
  • Imidacloprid

Product identification

Medicine name:
Ataxxa 500 mg/100 mg spot-on solution for dogs over 4 kg up to 10 kg
Ataxxa 500 mg - 100 mg Spot-on oplossing
Ataxxa 500 mg - 100 mg Solution pour spot-on
Ataxxa 500 mg - 100 mg Lösung zum Auftropfen
Active substance:
  • Permethrin
  • Imidacloprid
Target species:
  • Dog
Route of administration:
  • Topical use

Product details

Active substance and strength:
  • Permethrin
    500.00
    milligram(s)
    /
    1.00
    Pipette
  • Imidacloprid
    100.00
    milligram(s)
    /
    1.00
    Pipette
Pharmaceutical form:
  • Spot-on solution
Withdrawal period by route of administration:
  • Topical use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP53AC54
Authorisation status:
  • Valid
Authorised in:
  • Belgium
Package description:
  • White polypropylene pipette closed with either a polyethylene or polyoxymethylene cap. Each pipette is packed in a polyethylene terephthalate/aluminium/low density polyethylene triplex bag. 3 ml pipette containing 1 ml of solution. Box containing 10 pipettes.
  • White polypropylene pipette closed with either a polyethylene or polyoxymethylene cap. Each pipette is packed in a polyethylene terephthalate/aluminium/low density polyethylene triplex bag. 3 ml pipette containing 1 ml of solution. Box containing 6 pipettes.
  • White polypropylene pipette closed with either a polyethylene or polyoxymethylene cap. Each pipette is packed in a polyethylene terephthalate/aluminium/low density polyethylene triplex bag. 3 ml pipette containing 1 ml of solution. Box containing 4 pipettes.
  • White polypropylene pipette closed with either a polyethylene or polyoxymethylene cap. Each pipette is packed in a polyethylene terephthalate/aluminium/low density polyethylene triplex bag. 3 ml pipette containing 1 ml of solution. Box containing 3 pipettes.
  • White polypropylene pipette closed with either a polyethylene or polyoxymethylene cap. Each pipette is packed in a polyethylene terephthalate/aluminium/low density polyethylene triplex bag. 3 ml pipette containing 1 ml of solution. Box containing 1 pipettes.

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • KRKA tovarna zdravil d.d. Novo mesto
Marketing authorisation date:
Manufacturing sites for batch release:
  • Tad Pharma GmbH
  • Krka d.d. Novo Mesto
Responsible authority:
  • Federal Agency For Medicines And Health Products
Authorisation number:
  • BE-V490986
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0439/002
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Croatia
  • Czechia
  • Estonia
  • France
  • Germany
  • Hungary
  • Italy
  • Latvia
  • Lithuania
  • Netherlands
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 28/01/2022
Download
Dutch (PDF)
Published on: 22/03/2023
French (PDF)
Published on: 22/03/2023
German (PDF)
Published on: 22/03/2023

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 22/03/2023
French (PDF)
Published on: 22/03/2023
German (PDF)
Published on: 22/03/2023
How useful was this page?:
Average: 1 (6 votes)
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."